Liraglutide: a new option in the management of type 2 diabetes
Future Prescriber · 2008
DOI: 10.1002/fps.10 ↗Santrauka
Abstract Type 2 diabetes mellitus (T2DM) is a global epidemic with an expected prevalence of 380 million in 2025 worldwide 1 and over 2.5 million by 2010 in the UK. 2 Diabetes is a progres‐sive disease which leads to macro and microvascular complications and reduced life expectancy. 2 Furthermore, diabetes‐related complications have been shown to worsen patients' quality of life. 3,4 Copyright © 2008 John Wiley & Sons, Ltd.
EUVIMED